Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity.
about
Activity of soluble OX40 ligand is enhanced by oligomerization and cell surface immobilizationFLICE-inhibitory proteins: regulators of death receptor-mediated apoptosisMother's little helpers: mechanisms of maternal-fetal toleranceInduction of stress response renders human tumor cell lines resistant to curcumin-mediated apoptosis: role of reactive oxygen intermediatesA Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.Death induced by CD95 or CD95 ligand elimination.Opposing roles for membrane bound and soluble Fas ligand in glaucoma-associated retinal ganglion cell death.Biology and significance of T-cell apoptosis in the liver.The contribution of the Fas/FasL apoptotic pathway in ulcer formation during Leishmania major-induced cutaneous Leishmaniasis.The role of CD95 in the regulation of peripheral T-cell apoptosis.CD95 ligand--death factor and costimulatory molecule?CD95 and CD95L promote and protect cancer stem cellsTwo CD95 tumor classes with different sensitivities to antitumor drugs.A vision of cell death: Fas ligand and immune privilege 10 years later.T-cell death and cancer immune tolerance.Membrane-bound Fas ligand requires RIP1 for efficient activation of caspase-8 within the death-inducing signaling complexDeath receptors as targets for anti-cancer therapy.Targeting the Fas/FasL signaling pathway in cancer therapy.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.A novel signaling mechanism for soluble CD95 ligand. Synergy with anti-CD95 monoclonal antibodies for apoptosis and NF-kappaB nuclear translocation.Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.Signaling active CD95 receptor molecules trigger co-translocation of inactive CD95 molecules into lipid raftsMassive hepatic apoptosis associated with TGF-beta1 activation after Fas ligand treatment of IGF binding protein-1-deficient miceCD95 ligand induces motility and invasiveness of apoptosis-resistant tumor cells.Apoptosis-inducing membrane vesicles. A novel agent with unique properties.Alteration of Fas and Fas ligand expression during human visceral leishmaniasis.Monocytes stimulated with group B streptococci or interferons release tumour necrosis factor-related apoptosis-inducing ligand.Defects in the regulatory clearance mechanisms favor the breakdown of self-tolerance during spontaneous autoimmune orchitis.Membrane-bound CD95 ligand expressed on human antigen-presenting cells prevents alloantigen-specific T cell response without impairment of viral and third-party T cell immunity
P2860
Q24318411-9F6AA023-E88B-4C03-832C-36EE51235D8EQ24548247-5A6B8760-743C-494F-891D-9E2B0AF0FBE8Q28297770-1E33F758-2B24-4A0C-8A16-AD069F863C9CQ28345137-3CF47D5F-5807-4572-8521-D32AF856EDC5Q30252954-DBEE28C5-C37A-446F-A4EF-D9F23166B123Q30582837-09320A55-A14E-4D98-A6E8-2BACDEEE0AF6Q33867607-B46F8988-B0CC-426D-9BA0-C917ECFAD81AQ34546442-6E025B14-CB24-46EF-83D2-7EE276FF34D3Q35083834-EEDC0CC0-8877-451C-AEA7-406013671BE5Q35129712-0E65573E-74B9-4D7B-9DB9-71D007222FFAQ35190128-DB71F032-F74F-42B3-B493-5CB5718CC2CAQ35562681-5541B8F3-EEEE-4547-B2E2-24E1B8DFD1B1Q36161031-E4EDCCEF-3AA4-448E-B9CB-F9CEF977137BQ36593770-5A16C2E7-86FF-408B-A09C-2DA9CD953ECBQ37002795-E6C21BEE-CF93-404E-A6FA-40EAB8A1945EQ37314479-A8F1AF8A-74C2-433B-A336-B6906BF2AACDQ37390893-39ADB1FD-7196-4763-AD2E-F1DA513FE9C4Q37975245-54A7A2A0-18BD-4CA8-AAA9-59714A3E7249Q38120535-CE62C245-D9A0-44E3-8975-68E409FBF359Q38361696-96681CE9-DB9E-4AFC-B463-7823E15642A8Q38659118-68F5098F-FDB1-42C6-AF20-8977B119FEBFQ39340173-4AF22822-4811-4C29-B7F3-3D7F10B96B6BQ39740877-94F3E34D-8FE1-4BD5-9984-43CBB753C672Q39959143-C641C58D-706A-42CE-9741-0F7998BF324BQ42825776-68F94516-53B7-4B15-8D13-B9B1AC9718E0Q43990705-7A898820-7D84-47F4-B462-1DAAADBF758DQ44967034-2F2C1580-A23E-4944-9C0A-A6350E91B3FCQ46217375-E42636FF-B5BD-4AE5-9D55-629C9BD069DBQ57384575-A3612D47-0C6A-4E09-BB5C-4D8161ED9602
P2860
Extracellular matrix interacts with soluble CD95L: retention and enhancement of cytotoxicity.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Extracellular matrix interacts ...... d enhancement of cytotoxicity.
@en
type
label
Extracellular matrix interacts ...... d enhancement of cytotoxicity.
@en
prefLabel
Extracellular matrix interacts ...... d enhancement of cytotoxicity.
@en
P2093
P2860
P356
P1433
P1476
Extracellular matrix interacts ...... d enhancement of cytotoxicity.
@en
P2093
P2860
P304
P356
10.1038/86336
P407
P577
2001-04-01T00:00:00Z